Not applicableUnknownNCT04808856What this trial is testingTreatment of Refractory Gout With ACTH or MethylprednisoloneWho this might be right forGout Shanghai 10th People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00111657What this trial is testingPegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory GoutWho this might be right forGout John Sundy 30
Large-scale testing (Phase 3)Study completedNCT04596540What this trial is testingSEL-212 in Patients With Gout Refractory to Conventional Therapy IIWho this might be right forChronic Gout Swedish Orphan Biovitrum 153
Not applicableStudy completedNCT01466166What this trial is testingObservational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic GoutWho this might be right forRefractory Chronic Gout Horizon Pharma Rheumatology LLC 188
Very early researchUnknownNCT05800041What this trial is testingA Exploratory Trial of WTX221 in Refractory Gout PatientsWho this might be right forGout Tophus RenJi Hospital 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT07116746What this trial is testingEvaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed PatientsWho this might be right forGoutGouty ArthritisHyperuricemia+4 more Arthrosi Therapeutics 15
Testing effectiveness (Phase 2)Study completedNCT02598596What this trial is testingTolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering EffectWho this might be right forGout Ampel BioSolutions, LLC 132
Not applicableNot Yet RecruitingNCT06653686What this trial is testingStudy on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory GoutWho this might be right forRefractory Gout The First Hospital of Jilin University 128
Large-scale testing (Phase 3)Study completedNCT00675103What this trial is testingRe-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout PatientsWho this might be right forChronic Gout Refractory to Conventional Therapy Savient Pharmaceuticals 7
Post-approval studies (Phase 4)Study completedNCT04762498What this trial is testingA Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)Who this might be right forUncontrolled GoutChronic Gout Amgen 54
Post-approval studies (Phase 4)Study completedNCT06229145What this trial is testingA Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory GoutWho this might be right forGout Amgen 306
Testing effectiveness (Phase 2)Study completedNCT00080210What this trial is testingPersons With Gout Who Do Not Respond to or Are Allergic to Conventional TherapyWho this might be right forGout Savient Pharmaceuticals 40
Early research (Phase 1)Looking for participantsNCT07587684What this trial is testingIN026 in Participants With Refractory GoutWho this might be right forRefractory Gout Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 16
Testing effectiveness (Phase 2)Study completedNCT00798369What this trial is testingTargeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout PatientsWho this might be right forAcute Gout Novartis 200
Testing effectiveness (Phase 2)Study completedNCT03905512What this trial is testingCompare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional TherapyWho this might be right forChronic Gout Selecta Biosciences, Inc. 170
Large-scale testing (Phase 3)Study completedNCT04513366What this trial is testingSEL-212 in Patients With Gout Refractory to Conventional TherapyWho this might be right forChronic Gout Swedish Orphan Biovitrum 112